Aldose reductase inhibitor tablet targeting diabetic neuropathy complications. Acquired by specialized diabetes centers and hospital pharmacies. Developed by pharmaceutical companies, supplied through B2B channels to neurologists and endocrinologists in outpatient treatment protocols.